Evidence map›Paper›PMID 37518003›Full record

ReviewBMC public health2023

A rapid landscape review of postpartum anaemia measurement: challenges and opportunities.

Jennifer Yourkavitch, Hiromi Obara, Gulnoza Usmanova, Katherine E A Semrau, Ann-Beth Moller, Maria Nieves Garcia-Casal, Jahnavi Daru

Open access · goldAbstract readReview
In one paragraph

Review in BMC public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 15 citations in OpenAlex.

  1. Postpartum anemia and maternal wellbeing: A cohort analysis of the WOMAN-2 trial.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2026
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 4 countries.

Jennifer YourkavitchResults for Development Institute, Washington, DC, USA. jyourkavitch@r4d.org.
Hiromi ObaraNational Center for Global Health and Medicine, Bureau of International Health Cooperation, Tokyo, Japan.
Gulnoza UsmanovaJhpiego India Country Office, New Delhi, India.
Katherine E A SemrauAriadne Labs | Brigham & Women's Hospital and Harvard TH Chan School of Public Health, Boston, MA, USA and Harvard Medical School, Boston, MA, USA.
Ann-Beth MollerUNDP/UNFPA/ UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), World Health Organization Department of Sexual and Reproductive Health and Research, Geneva, Switzerland.
Maria Nieves Garcia-CasalWorld Health Organization Department of Nutrition and Food Safety, Geneva, Switzerland.
Jahnavi DaruWolfson Institute of Population Health Science, Women's Health Research Unit, Queen Mary University of London, London, UK.
World Health Organization · CHBrigham and Women's Hospital · USNational Center for Global Health and Medicine · JPQueen Mary University of London · GBResults for Development Institute · US

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundAnaemia is a reduction in haemoglobin concentration below a threshold, resulting from various factors including severe blood loss during and after childbirth. Symptoms of anaemia include fatigue and weakness, among others, affecting health and quality of life. Anaemic pregnant women have an increased risk of premature delivery, a low-birthweight infant, and postpartum depression. They are also more likely to have anaemia in the postpartum period which can lead to an ongoing condition and affect subsequent pregnancies. In 2019 nearly 37% of pregnant women globally had anaemia, and estimates suggest that 50-80% of postpartum women in low- and middle-income countries have anaemia, but currently there is no standard measurement or classification for postpartum anaemia.

methodsA rapid landscape review was conducted to identify and characterize postpartum anaemia measurement searching references within three published systematic reviews of anaemia, including studies published between 2012 and 2021. We then conducted a new search for relevant literature from February 2021 to April 2022 in EMBASE and MEDLINE using a similar search strategy as used in the published reviews.

resultsIn total, we identified 53 relevant studies. The timing of haemoglobin measurement ranged from within the immediate postpartum period to over 6 weeks. The thresholds used to diagnose anaemia in postpartum women varied considerably, with < 120, < 110, < 100 and < 80 g/L the most frequently reported. Other laboratory results frequently reported included ferritin and transferrin receptor. Clinical outcomes reported in 32 out of 53 studies included postpartum depression, quality of life, and fatigue. Haemoglobin measurements were performed in a laboratory, although it is unclear from the studies if venous samples and automatic analysers were used in all cases.

conclusionsThis review demonstrates the need for improving postpartum anaemia measurement given the variability observed in published measures. With the high prevalence of anaemia, the relatively simple treatment for non-severe cases of iron deficiency anaemia, and its importance to public health with multi-generational effects, it is crucial to develop common measures for women in the postpartum period and promote rapid uptake and reporting.

Indexed as

AnemiaAnemia, Iron-DeficiencyDepression, PostpartumFatigueFemaleHemoglobinsHumansIronPostpartum PeriodPregnancyQuality of LifeHemoglobinsIronAnaemia measurementPostpartum anaemiaWomen’s health

Identifiers

PMID37518003
PMCPMC10388528
OpenAlexW4385396192

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.